(Q31103326)

English

Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 June 2017

Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data (English)

1 reference

Europe PubMed Central

28 June 2017

immunization safety

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Katrin Susanne Kohl

23

object named as

Katrin Kohl

1 reference

Europe PubMed Central

28 June 2017

32

object named as

James Sejvar

1 reference

Europe PubMed Central

28 June 2017

Ulrich Heininger

15

object named as

Ulrich Heininger

1 reference

Europe PubMed Central

28 June 2017

Brigid C Bollweg

4

object named as

Brigid Bollweg

1 reference

Europe PubMed Central

28 June 2017

David R. Cornblath

7

object named as

David Cornblath

1 reference

Europe PubMed Central

28 June 2017

author name string

Barbara Rath

1

1 reference

Europe PubMed Central

28 June 2017

Jane F Gidudu

2

1 reference

Europe PubMed Central

28 June 2017

Helen Anyoti

3

1 reference

Europe PubMed Central

28 June 2017

Patrick Caubel

5

1 reference

Europe PubMed Central

28 June 2017

Yeoung-Hwang Chen

6

1 reference

Europe PubMed Central

28 June 2017

Rohini Fernandopulle

8

1 reference

Europe PubMed Central

28 June 2017

Louis Fries

9

1 reference

Europe PubMed Central

28 June 2017

Jochem Galama

10

1 reference

Europe PubMed Central

28 June 2017

Neville Gibbs

11

1 reference

Europe PubMed Central

28 June 2017

Gualtiero Grilli

12

1 reference

Europe PubMed Central

28 June 2017

Patrick Grogan

13

1 reference

Europe PubMed Central

28 June 2017

Katharina Hartmann

14

1 reference

Europe PubMed Central

28 June 2017

Michael J Hudson

16

1 reference

Europe PubMed Central

28 June 2017

Hector S Izurieta

17

1 reference

Europe PubMed Central

28 June 2017

Indira Jevaji

18

1 reference

Europe PubMed Central

28 June 2017

Wiltshire M Johnson

19

1 reference

Europe PubMed Central

28 June 2017

James Jones

20

1 reference

Europe PubMed Central

28 June 2017

Brigitte Keller-Stanislawski

21

1 reference

Europe PubMed Central

28 June 2017

Jerome Klein

22

1 reference

Europe PubMed Central

28 June 2017

Panagiotis Kokotis

24

1 reference

Europe PubMed Central

28 June 2017

Yulin Li

25

1 reference

Europe PubMed Central

28 June 2017

Thomas Linder

26

1 reference

Europe PubMed Central

28 June 2017

James Oleske

27

1 reference

Europe PubMed Central

28 June 2017

Georgina Richard

28

1 reference

Europe PubMed Central

28 June 2017

Tarek Shafshak

29

1 reference

Europe PubMed Central

28 June 2017

Michael Vajdy

30

1 reference

Europe PubMed Central

28 June 2017

Virginia Wong

31

1 reference

Europe PubMed Central

28 June 2017

Brighton Collaboration Bell's Palsy Working Group

33

1 reference

Europe PubMed Central

28 June 2017

language of work or name

0 references

publication date

24 May 2016

1 reference

Europe PubMed Central

28 June 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

28 June 2017

35

1 reference

Europe PubMed Central

28 June 2017

1972-1983

1 reference

Europe PubMed Central

28 June 2017

15

1 reference

Europe PubMed Central

28 June 2017

Facial nerve palsy: etiology and approach to diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

When is facial paralysis Bell palsy? Current diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bilateral simultaneous Bell's palsy. Two cases following herpes simplex gingivostomatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

A case presentation of bilateral simultaneous Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bilateral simultaneous facial nerve palsy: clinical analysis in seven cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bilateral simultaneous facial nerve palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bilateral facial nerve palsy associated with Epstein-Barr virus infection with a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bell's palsy. Nonrecurrent v recurrent and unilateral v bilateral

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Neurological complications following rubella infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Secretion and dynamics of herpes simplex virus in tears and saliva of patients with Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Herpes Simplex Virus in Idiopathic Facial Paralysis (Bell Palsy)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Posttraumatic Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Facial nerve palsy in a thirteen-year-old male youth with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Idiopathic Facial Paralysis, Pregnancy, and the Menstrual Cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Association between Bell's palsy in pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Peripheral facial palsy: etiology, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bell's palsy in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Familial Bell's palsy in females: a phenotype with a predilection for eyelids and lacrimal gland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Recent developments in Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Incidence and risk factors for Bell's palsy in Laredo, Texas: 1974-1982

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The epidemiology and treatment of Bell's palsy in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Early treatment with prednisolone or acyclovir in Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Evaluation of a physiotherapeutic treatment intervention in "Bell's" facial palsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Prognosis of Bell's palsy in children--analysis of 29 cases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bell's palsy associated with influenza vaccination: two case reports.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Rare adverse events associated with oral poliovirus vaccine in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Adverse events reported following live, cold-adapted, intranasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Issues in the design and implementation of vaccine trials in less developed countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The development of standardized case definitions and guidelines for adverse events following immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Seasonal patterns of idiopathic facial paralysis: a 16-year study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Time course of Bell palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Antiviral therapy for neurological manifestations of enterovirus 71 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Herpes simplex virus type 1 reactivation and antiviral therapy in patients with acute peripheral facial palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The role of viruses in idiopathic peripheral facial palsy and cellular immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Herpes simplex virus in the saliva of peripheral Bell's palsy patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bell's palsy and Herpes simplex virus: fact or mystery?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Herpes-simplex virus as a cause of Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Herpes simplex virus as a cause of Bell's palsy. 1972.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Demyelination associated with HSV-1-induced facial paralysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Leprosy and the eye: a review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Diagnosis, treatment, and prevention of Lyme disease in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Central nervous system Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Miliary Tuberculosis in Children: A Clinical Review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Pneumococcal acute otitis media in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Viral upper respiratory tract infections in young children with emphasis on acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Chronic suppurative otitis media: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Cephalic tetanus following minor facial abrasions: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Cephalic tetanus: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Cephalic tetanus as a result of rooster pecking: an unusual case

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Tick-borne diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Ramsay Hunt syndrome in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Characteristics of facial nerve palsy during childhood in Japan: frequency of varicella-zoster virus association.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Ramsay Hunt syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Diagnosis please. Case 16: facial nerve schwannoma with middle cranial fossa involvement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Paraneoplastic rhombencephalitis and brachial plexopathy in two cases of amphiphysin auto-immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Sudden onset aphasic hemiplegia: an unusual manifestation of disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Pediatric bilateral facial paralysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Incomplete Kawasaki disease: not to be forgotten

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Cranial Polyneuritis and Bell Palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Immune reactivity in Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Role of T-lymphocyte subsets in facial nerve paralysis owing to the reactivation of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Immunological concept for Bell's palsy: further experimental study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Seventh nerve palsies may be the only clinical sign of small pontine infarctions in diabetic and hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Relationship of phytohaemagglutinin-induced lymphocyte transformation to disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Facial nerve palsy in the newborn: incidence and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Minor trauma, disastrous results

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Reactivation of herpes simplex virus type 1 in patients with Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Peripheral facial nerve paralysis of dental origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Management of petrous bone fractures in children: analysis of 127 cases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Bell's palsy in pregnancy: a study of recovery outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Characteristics of cranial nerve palsies in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Effects of climate, latitude, and season on the incidence of Bell's palsy in the US Armed Forces, October 1997 to September 1999

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

[Peripheral facial paralysis associated with anti-tetanic serotherapy: a case report]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Agreement between the Sunnybrook, House-Brackmann, and Yanagihara facial nerve grading systems in Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The comparison of facial grading systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Objective grading of facial paralysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Reliability of the "Sydney," "Sunnybrook," and "House Brackmann" facial grading systems to assess voluntary movement and synkinesis after facial nerve paralysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Computer-assisted clinimetric tool for the study of facial expression: a pilot validity study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Facial nerve grading systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Facial nerve grading system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Facial nerve grading systems (1985-2002): beyond the House-Brackmann scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

An analysis of the Adour-Swanson and House-Brackmann grading systems for facial nerve recovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The Nottingham System: objective assessment of facial nerve function in the clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Measurement of facial movement with computer software

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Objective evaluation of normal facial function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Evaluation of a new measurement tool for facial paralysis reconstruction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Facial Nerve Grading System 2.0.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Evaluation of facial palsy by moiré topography index

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Quantitative assessment of the variation within grades of facial paralysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

CONSORT: An Evolving Tool to Help Improve the Quality of Reports of Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

The True Nature of Bell's Palsy: Analysis af 1,000 Consecutive Patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

based on heuristic

inferred from DOI database lookup

An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired specific cellular immunity to the varicella-zoster virus in patients with herpes zoster oticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2016.05.023

1 reference

Europe PubMed Central

28 June 2017

1 reference

Europe PubMed Central

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31103326&oldid=1960446248"